ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

REXN Rexahn Pharmaceuticals Inc

1.81
0.00 (0.00%)
14 Jun 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 17.9M14.57M48.99M45.4M43.47M54.19M53.95M51.84M
Total Current Assets 17.89M14.56M48.99M45.4M43.46M54.19M53.95M51.84M
Cash and Equivalents 17.03M13.86M42.63M38.99M39.98M42.35M50.5M47.16M
Total Non-Current Assets 16k7k12k10k8k6k00
Total Liabilities 3.3M2.69M2.75M4.15M5.76M3.91M4.04M5.79M
Total Current Liabilities 3.3M2.69M2.75M4.15M5.76M3.91M4.04M5.79M
Total Non-Current Liabilities 00000000
Common Equity 2k2k2k2k2k2k2k3k
Retained Earnings -100.89M-105.42M-71.48M-77.27M-82.23M-76.67M-81.47M-88.57M
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 21.04M28.29M16.04M12.97M17.68M26.08M48.99M53.95M
Total Current Assets 20.92M28.14M15.9M12.66M17.67M26.07M48.99M53.95M
Cash and Equivalents 11.58M8.9M8.74M9.22M16.4M24.53M42.63M50.5M
Total Non-Current Assets 17.06M16.77M10.56M9.96M-13.47M22.22M46.24M49.91M
Total Liabilities 3.99M11.52M5.48M3.01M31.15M3.86M2.75M4.04M
Total Current Liabilities 1.88M3.23M3.15M2.91M3.19M3.86M2.75M4.04M
Total Non-Current Liabilities 2.1M8.29M2.33M106k27.96M000
Total Equity 17.06M16.77M10.56M9.96M-13.47M22.22M46.24M49.91M
Common Equity 24k3k4k01,0002k2k2k
Retained Earnings -115.03M-140.32M-154.69M-163.32M-32.68M-89.37M-71.48M-81.47M

Your Recent History

Delayed Upgrade Clock